Entry |
|
Symbol |
E2F3
|
Name |
(RefSeq) transcription factor E2F3 isoform X1
|
KO |
K06620 | transcription factor E2F3 |
|
Organism |
pps Pan paniscus (bonobo)
|
Pathway |
pps05163 | Human cytomegalovirus infection |
pps05166 | Human T-cell leukemia virus 1 infection |
pps05167 | Kaposi sarcoma-associated herpesvirus infection |
|
Brite |
KEGG Orthology (KO) [BR:pps00001]
09140 Cellular Processes
09143 Cell growth and death
04110 Cell cycle
100986032 (E2F3)
04218 Cellular senescence
100986032 (E2F3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100986032 (E2F3)
05206 MicroRNAs in cancer
100986032 (E2F3)
09162 Cancer: specific types
05212 Pancreatic cancer
100986032 (E2F3)
05225 Hepatocellular carcinoma
100986032 (E2F3)
05226 Gastric cancer
100986032 (E2F3)
05214 Glioma
100986032 (E2F3)
05220 Chronic myeloid leukemia
100986032 (E2F3)
05218 Melanoma
100986032 (E2F3)
05219 Bladder cancer
100986032 (E2F3)
05215 Prostate cancer
100986032 (E2F3)
05224 Breast cancer
100986032 (E2F3)
05222 Small cell lung cancer
100986032 (E2F3)
05223 Non-small cell lung cancer
100986032 (E2F3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100986032 (E2F3)
05161 Hepatitis B
100986032 (E2F3)
05160 Hepatitis C
100986032 (E2F3)
05163 Human cytomegalovirus infection
100986032 (E2F3)
05167 Kaposi sarcoma-associated herpesvirus infection
100986032 (E2F3)
05169 Epstein-Barr virus infection
100986032 (E2F3)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
100986032 (E2F3)
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
100986032 (E2F3)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:pps03000]
100986032 (E2F3)
Transcription factors [BR:pps03000]
Eukaryotic type
Helix-turn-helix
Fork head/winged helix cell cycle-controlling factors, E2F
100986032 (E2F3)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
5:35036930..35128398
|
AA seq |
465 aa
MRKGIQPALEQYLVTAGGGEGAAVVAAAAAASMDKRALLASPGFAAAAAAAAAPGAYIQI
LTTNTSTTSCSSSLQSGAVAAGPLLPSAPGAEQTAGSLLYTTPHGPSSRAGLLQQPPALG
RGGSGGGGGPPAKRRLELGESGHQYLSDGLKTPKGKGRAALRSPDSPKTPKSPSEKTRYD
TSLGLLTKKFIQLLSQSPDGVLDLNKAAEVLKVQKRRIYDITNVLEGIHLIKKKSKNNVQ
WMGCSLSEDGGMLAQCQGLSKEVTELSQEEKKLDELIQSCTLDLKLLTEDSENQRLAYVT
YQDIRKISGLKDQTVIVVKAPPETRLEVPDSIESLQIHLASTQGPIEVYLCPEETETHSP
MKTNNQDHNGNIPKPASKDLASTNSGHSDCSISMGNLSPLASPANLLQQTEDQIPSNLEG
PFVNLLPPLLQEDYLLSLGEEEGISDLFDAYDLEKLPLVEDFMCS |
NT seq |
1398 nt +upstreamnt +downstreamnt
atgagaaaggggatccagcccgctctggagcagtacctggtgaccgccgggggtggggag
ggggcggctgtcgtcgccgccgccgctgcagcctccatggacaaaagggcactgctagcc
agccccggcttcgccgccgccgccgccgctgccgccgccccgggcgcgtacatccagatc
ctcaccacgaacacttccaccacctcctgttcctcctccctccaaagcggcgccgtagcc
gccggccccctcctccccagtgcccccggcgcggagcagaccgccggcagcctcctctac
accacgccgcacggaccctccagcagagccgggctgctgcagcagccaccagcgctggga
cgcggcggcagcggcggcggcggcggccctccggcaaagcgaaggctggagctaggagaa
agcggtcatcagtacctctcagatggtttaaaaacccccaagggcaaaggaagagctgca
ctacgaagtccagatagtccaaaaactccaaaatctccctcagaaaaaacgcggtatgat
acgtctcttggtctgctcaccaagaagttcattcagctcctgagccagtcacccgatggg
gtattggatttgaacaaggcagcagaagtgctaaaagtgcaaaagagaaggatttatgat
atcaccaacgttctggaaggcatccacctcattaagaagaagtctaaaaacaacgtccaa
tggatgggctgcagtctgtctgaggatgggggcatgctggcccagtgtcaaggcctgtca
aaagaagtgaccgagctcagtcaggaagagaagaaattagatgaactgatccaaagctgc
accctggacctcaaactgttaaccgaggattcagagaatcaaaggttagcttatgttaca
tatcaagatattcgaaaaattagtggccttaaagaccaaactgttatagttgtgaaagcc
cctccagaaacaagacttgaagtgcctgactcaatagagagcctacaaatacatttggca
agtacccaagggcccattgaggtttacttatgtccagaagagactgaaacacacagtcca
atgaaaacaaacaaccaagaccacaatgggaatatccctaaacccgcttccaaagacttg
gcttcaaccaactcaggacatagcgattgctcaatttctatgggaaacctttctcctctg
gcctccccagccaacctcttacagcagactgaggaccaaattccttccaacctagaagga
ccctttgtgaacttactgcctcccctgctgcaagaggactatctcctgagcctcggggag
gaggaaggcatcagcgatctcttcgatgcttacgatttggaaaagctcccactggtggaa
gacttcatgtgtagttga |